AVLX-144
- Generic Name
- AVLX-144
A Phase 1 Study in Healthy Volunteers to Evaluate the Safety, Tolerability and Pharmacokinetics of AVLX-144
- First Posted Date
- 2020-12-30
- Last Posted Date
- 2023-07-20
- Lead Sponsor
- Avilex Pharma
- Target Recruit Count
- 46
- Registration Number
- NCT04689035
- Locations
- 🇫🇮
Clinical Research Services Turku / CRST Oy, Turku, Finland
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath